Review





Similar Products

96
Agilent technologies advancebio peptide mapping column
Advancebio Peptide Mapping Column, supplied by Agilent technologies, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/peptides/AdvanceBio+Peptide+Mapping/pm42956583-147-11-23
Average 96 stars, based on 1 article reviews
advancebio peptide mapping column - by Bioz Stars, 2026-11
96/100 stars
  Buy from Supplier

96
InvivoGen peptide m agarose
Peptide M Agarose, supplied by InvivoGen, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/peptides/Peptide+M+Agarose/pm42956746-278-4-7
Average 96 stars, based on 1 article reviews
peptide m agarose - by Bioz Stars, 2026-11
96/100 stars
  Buy from Supplier

90
Cerapedics i-factor peptide enhanced bone graft
I Factor Peptide Enhanced Bone Graft, supplied by Cerapedics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/peptides/i+factor+peptide+enhanced+bone+graft/nct05038527-110-10-18
Average 90 stars, based on 1 article reviews
i-factor peptide enhanced bone graft - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

94
ALPCO human c peptide elisa kit
Human C Peptide Elisa Kit, supplied by ALPCO, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/peptides/C-Peptide+ELISA/pm42962661-921-11-15
Average 94 stars, based on 1 article reviews
human c peptide elisa kit - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

97
InvivoGen ova peptide
Ova Peptide, supplied by InvivoGen, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/peptides/OVA+323-339/pm42998252-265-0-5
Average 97 stars, based on 1 article reviews
ova peptide - by Bioz Stars, 2026-11
97/100 stars
  Buy from Supplier

98
MedChemExpress peptide 740y p
Peptide 740y P, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/peptides/740+Y-P/pm42981166-65-2-7
Average 98 stars, based on 1 article reviews
peptide 740y p - by Bioz Stars, 2026-11
98/100 stars
  Buy from Supplier

94
MedChemExpress gip peptide
Gip Peptide, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/peptides/GIP%2C+human/pm42980901-56-41-45
Average 94 stars, based on 1 article reviews
gip peptide - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

94
R&D Systems plaqav dpa rsssr nh2 fluorogenic peptide substrate iii
Plaqav Dpa Rsssr Nh2 Fluorogenic Peptide Substrate Iii, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/peptides/Mca-PLAQAV-Dpa-RSSSR-NH2+Fluorogenic+Peptide+Substrate/pm42979410-90-14-27
Average 94 stars, based on 1 article reviews
plaqav dpa rsssr nh2 fluorogenic peptide substrate iii - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

94
MedChemExpress peptide antagonist epi x4
(A) CellChat cell-cell communication analysis of chemokine pathways between structural cells and CD8+ T cell states nominated by proportionality analysis in . (B) Dot plot of Cxcl12 and Ccl19 expression scaled by z-score in T2 single-cell timecourse. (C) CXCL12 and CCL19 protein levels in ear skin lysates across primary and secondary MC903. (D) Dot plot of single-cell fibroblast CCL19 expression across healthy (H), AD non-lesional (NL) and AD lesional (L) human skin. (E) Proportion of CXCR4+ cells across immune cell subtypes present in skin on D13 of T2 inflammation (n=18 mice). (F) Ear thickness curve of primary MC903 with treatment by <t>EPI-X4</t> to block CXCR4-mediated recruitment (n=25 mice/condition). EPI-X4 or ethanol vehicle-control treatment days are denoted by arrows. (G) Immune cell representation in D13 skin after EPI-X4 treatment (n=6 mice/condition). (H) Explant schematic and Ccl19 qPCR after 20-hour culture (n=5 explants). (I) Schematic of Transwell CD8+ T cell migration assays to explant-conditioned media with antibody-mediated CCL19 blockade. Migrated CD8+ T cells in the lower chamber were counted by flow cytometry (n=3 explants/condition). (J) Heatmap of Ccl19 expression by primary fibroblasts after Trm-derived cytokine stimulation measured by bulk RNA-seq (n=8 mice/condition). (K) Schematic of TNF-α blockade prior to T2 recall with ELISA measurement of CCL19 levels on D37 in ear skin lysates (n=8 (Iso), 9 (α-TNF-α) mice). (L) One-day ear thickness changes with TNF-α blockade (n=8 mice/condition). (M) Quantification of abundance of NK1.1+ cells and T cells in D37 skin after TNF-α blockade (n=8 mice/condition). (N) Concentration of IL-4 in skin lysates in T2 memory (n=4 mice/timepoint). (O) Left: Schematic illustrating hypothesized interaction between IL-4 and TNF-α signaling in iFBs. Right: qPCR analysis of primary dermal fibroblasts stimulated with IL-4, TNF-α or the combination for 48 hours (n=3 mice/condition).
Peptide Antagonist Epi X4, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/peptides/EPI-X4/bio_rxiv__64898__2026__11__02__763646-461-6-9
Average 94 stars, based on 1 article reviews
peptide antagonist epi x4 - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

Image Search Results


(A) CellChat cell-cell communication analysis of chemokine pathways between structural cells and CD8+ T cell states nominated by proportionality analysis in . (B) Dot plot of Cxcl12 and Ccl19 expression scaled by z-score in T2 single-cell timecourse. (C) CXCL12 and CCL19 protein levels in ear skin lysates across primary and secondary MC903. (D) Dot plot of single-cell fibroblast CCL19 expression across healthy (H), AD non-lesional (NL) and AD lesional (L) human skin. (E) Proportion of CXCR4+ cells across immune cell subtypes present in skin on D13 of T2 inflammation (n=18 mice). (F) Ear thickness curve of primary MC903 with treatment by EPI-X4 to block CXCR4-mediated recruitment (n=25 mice/condition). EPI-X4 or ethanol vehicle-control treatment days are denoted by arrows. (G) Immune cell representation in D13 skin after EPI-X4 treatment (n=6 mice/condition). (H) Explant schematic and Ccl19 qPCR after 20-hour culture (n=5 explants). (I) Schematic of Transwell CD8+ T cell migration assays to explant-conditioned media with antibody-mediated CCL19 blockade. Migrated CD8+ T cells in the lower chamber were counted by flow cytometry (n=3 explants/condition). (J) Heatmap of Ccl19 expression by primary fibroblasts after Trm-derived cytokine stimulation measured by bulk RNA-seq (n=8 mice/condition). (K) Schematic of TNF-α blockade prior to T2 recall with ELISA measurement of CCL19 levels on D37 in ear skin lysates (n=8 (Iso), 9 (α-TNF-α) mice). (L) One-day ear thickness changes with TNF-α blockade (n=8 mice/condition). (M) Quantification of abundance of NK1.1+ cells and T cells in D37 skin after TNF-α blockade (n=8 mice/condition). (N) Concentration of IL-4 in skin lysates in T2 memory (n=4 mice/timepoint). (O) Left: Schematic illustrating hypothesized interaction between IL-4 and TNF-α signaling in iFBs. Right: qPCR analysis of primary dermal fibroblasts stimulated with IL-4, TNF-α or the combination for 48 hours (n=3 mice/condition).

Journal: bioRxiv

Article Title: A fibroblast-CD8+ T cell circuit drives a Type 1 shift in allergic inflammatory memory

doi: 10.64898/2026.11.02.763646

Figure Lengend Snippet: (A) CellChat cell-cell communication analysis of chemokine pathways between structural cells and CD8+ T cell states nominated by proportionality analysis in . (B) Dot plot of Cxcl12 and Ccl19 expression scaled by z-score in T2 single-cell timecourse. (C) CXCL12 and CCL19 protein levels in ear skin lysates across primary and secondary MC903. (D) Dot plot of single-cell fibroblast CCL19 expression across healthy (H), AD non-lesional (NL) and AD lesional (L) human skin. (E) Proportion of CXCR4+ cells across immune cell subtypes present in skin on D13 of T2 inflammation (n=18 mice). (F) Ear thickness curve of primary MC903 with treatment by EPI-X4 to block CXCR4-mediated recruitment (n=25 mice/condition). EPI-X4 or ethanol vehicle-control treatment days are denoted by arrows. (G) Immune cell representation in D13 skin after EPI-X4 treatment (n=6 mice/condition). (H) Explant schematic and Ccl19 qPCR after 20-hour culture (n=5 explants). (I) Schematic of Transwell CD8+ T cell migration assays to explant-conditioned media with antibody-mediated CCL19 blockade. Migrated CD8+ T cells in the lower chamber were counted by flow cytometry (n=3 explants/condition). (J) Heatmap of Ccl19 expression by primary fibroblasts after Trm-derived cytokine stimulation measured by bulk RNA-seq (n=8 mice/condition). (K) Schematic of TNF-α blockade prior to T2 recall with ELISA measurement of CCL19 levels on D37 in ear skin lysates (n=8 (Iso), 9 (α-TNF-α) mice). (L) One-day ear thickness changes with TNF-α blockade (n=8 mice/condition). (M) Quantification of abundance of NK1.1+ cells and T cells in D37 skin after TNF-α blockade (n=8 mice/condition). (N) Concentration of IL-4 in skin lysates in T2 memory (n=4 mice/timepoint). (O) Left: Schematic illustrating hypothesized interaction between IL-4 and TNF-α signaling in iFBs. Right: qPCR analysis of primary dermal fibroblasts stimulated with IL-4, TNF-α or the combination for 48 hours (n=3 mice/condition).

Article Snippet: CXCR4 signaling was inhibited using the peptide antagonist EPI-X4 (MedChemExpress HY-P10415) .

Techniques: Analysis, Expressing, Single Cell, Immune Cell, Blocking Assay, Control, Migration, Flow Cytometry, Derivative Assay, RNA Sequencing, Enzyme-linked Immunosorbent Assay, Concentration Assay, Significance Assay, Gene Expression